Novartis said it expects Entresto, its slow-to-take heart-failure medication, to generate $200 million in sales in 2016 as it kicks off a DTC campaign to help drive awareness of the drug. The spot is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback